SCHEMBL6130299

SCHEMBL6130299

NC(=S)N(N=Cc1cc(Br)cc(Br)c1O)c1ccc(C(=O)O)cc1.O=C(O)c1ccc(C=NNC(=S)Nc2cccc3ccccc23)c(O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.41
KMT2A Q03164 11/20 0.41
MAPT P10636 10/20 0.41
NPC1 O15118 5/20 0.41
RAB9A P51151 4/20 0.41
GAA P10253 3/20 0.41
POLB P06746 2/20 0.41
GFER P55789 1/20 0.41
MAPK1 P28482 2/20 0.41
MCL1 Q07820 1/20 0.40
LMNA P02545 5/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HPGD P15428 2/20 0.38
ALOX12 P18054 1/20 0.38
KDM4E B2RXH2 6/20 0.37
HTT P42858 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
PTPN1 P18031 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5364134 0.81 MAPT (0.53) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL5364129 0.81 MAPT (0.53) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL6130277 0.75 MAPT (0.47) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL6130315 0.73 KMT2A (0.41) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL6130287 0.73 KMT2A (0.40) MEN1KMT2AMAPTNPC1GAA
SCHEMBL5362822 0.71 MAPT (0.64) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL5362825 0.71 MAPT (0.64) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL5364913 0.70 MAPT (0.72) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL5364907 0.70 MAPT (0.72) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL5364167 0.69 MAPT (0.71) MEN1KMT2AMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1349613-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2005-09-21 EP disclosed
EP-1349613-A2 THROMBOPOIETIN MIMETICS SmithKline Beecham Corporation (US) 2003-10-08 EP disclosed
WO-2002049413-A2 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2002-06-27 WO disclosed